Click here for an accessible version of this site

What is Menactra vaccine?

Menactra vaccine is a safe and effective vaccine against meningococcal disease.1-4 Although rare, meningococcal disease is a serious bacterial illness that includes meningitis (the inflammation of the protective layer surrounding the brain and spinal cord) and septicemia (blood poisoning).2,3,5,6 Between 1000 and 2600 cases of meningococcal disease occur in the United States annually.2 Every year, the disease quickly ends the lives of children and can leave its survivors permanently disabled.1,3,8,9 Fortunately, you’re not powerless. Menactra vaccine can help.

Menactra vaccine helps protect children

  • A single shot can help reduce your chances of getting meningococcal disease, which includes meningitis.1,2
  • It helps protect against the most common strains of the meningitis bacteria (A, C, Y, and W-135) in the United States.1,3
  • The Centers for Disease Control and Prevention (CDC) recommends a meningococcal vaccine like Menactra for children 11 through 18 years of age.2
  • Menactra vaccine is manufactured and distributed by Sanofi Pasteur Inc., a company with a long history of firsts, including one of the first meningococcal meningitis vaccines, a quadrivalent polysaccharide vaccine, and now Menactra vaccine, the first and only quadrivalent conjugate vaccine licensed in the United States for the prevention against certain strains of meningococcal disease.2,3
NEXT: Why Menactra Vaccine?

What’s your story?

Share your personal experience with meningococcal disease and meningitis.

Ask for Menactra vaccine today

Vaccinating your children against meningococcal disease (which includes meningitis) is the best way to help protect them.

Indication
Menactra vaccine is given to persons 2 through 55 years of age for active immunization against invasive meningococcal disease caused by N meningitidis serogroups A, C, Y, and W-135. Menactra vaccine will not stimulate protection against infection caused by N meningitidis other than serogroups A, C, Y, and W-135.

Safety Information
Side effects to Menactra vaccine include injection site pain, redness, and swelling; headache or fatigue. Other side effects may occur. Vaccination should be avoided by persons with known hypersensitivity (severe allergic reaction) to any ingredient of the vaccine, including latex (which is used in the vial stopper), or by any persons previously diagnosed with Guillain-Barré syndrome. There is a potential for an increased chance of getting Guillain-Barré syndrome following vaccination. Vaccination with Menactra vaccine may not protect all individuals.

For more information about Menactra vaccine, talk to your health-care professional.